文献速递白血病

靶向FLT3的UniCAR T细胞治疗急性髓系白血病

FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2023-07-17

该临床前研究开发了靶向FMS样酪氨酸激酶3(FLT3)的UniCAR T细胞疗法,体外可高效杀伤AML细胞系和原代AML样本,并在小鼠异种移植模型中显示体内功能;PET分析显示FLT3靶向模块血清半衰期短,可实现UniCAR T细胞的快速开/关切换。

要点

  • 靶向FLT3的UniCAR T细胞在体外高效杀伤AML细胞系和原代AML样本。
  • 在小鼠异种移植模型中显示体内功能。
  • PET分析显示FLT3靶向模块血清半衰期短,可实现快速开/关切换。

核心结论

  • 所展示的临床前数据支持进一步开发和临床转化靶向FLT3的UniCAR T细胞用于AML治疗。

研究设计与样本

  • 临床前开发研究,体外杀伤实验使用AML细胞系和原代AML样本,体内功能在小鼠异种移植模型中评估,并用PET分析FLT3靶向模块的血清半衰期。

主要发现

  • 靶向FLT3的UniCAR T细胞在体外高效杀伤AML细胞系和原代AML样本。
  • 在小鼠异种移植模型中显示体内功能。
  • PET分析显示FLT3靶向模块血清半衰期短,可实现UniCAR T细胞的快速开/关切换。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adaptor chimeric antigen receptor (CAR) T-cell therapy offers solutions for improved safety and antigen escape, which represent main obstacles for the clinical translation of CAR T-cell therapy in myeloid malignancies. The adaptor CAR T-cell platform 'UniCAR' is currently under early clinical investigation. Recently, the first proof of concept of a well-tolerated, rapidly switchable, CD123-directed UniCAR T-cell product treating patients with acute myeloid leukaemia (AML) was reported. Relapsed and refractory AML is prone to high plasticity under therapy pressure targeting one single tumour antigen. Thus, targeting of multiple tumour antigens seems to be required to achieve durable anti-tumour responses, underlining the need to further design alternative AML-specific target modules (TM) for the UniCAR platform. We here present the preclinical development of a novel FMS-like tyrosine kinase 3 (FLT3)-directed UniCAR T-cell therapy, which is highly effective for in vitro killing of both AML cell lines and primary AML samples. Furthermore, we show in vivo functionality in a murine xenograft model. PET analyses further demonstrate a short serum half-life of FLT3 TMs, which will enable a rapid on/off switch of UniCAR T cells. Overall, the presented preclinical data encourage the further development and clinical translation of FLT3-specific UniCAR T cells for the therapy of AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Peschke JC, Bergmann R, Mehnert M, et al. FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia. Br J Haematol. 2023. PMID: 37460273. doi:10.1111/bjh.18971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。